References
- Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012;134(2):459–478. doi:https://doi.org/10.1007/s10549-012-2114-5
- Chirgwin JH, Giobbie-Hurder A, Coates AS, et al. Treatment adherence and its impact on disease-free survival in the Breast International Group 1-98 Trial of tamoxifen and letrozole, alone and in sequence. J Clin Oncol. 2016;34(21):2452–2459. doi:https://doi.org/10.1200/JCO.2015.63.8619
- Dezentje VO, van Blijderveen NJ, Gelderblom H, et al. Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. J Clin Oncol. 2010;28(14):2423–2429. doi:https://doi.org/10.1200/JCO.2009.25.0894
- Gabrys L, Jordan S, Schlaud M . Prevalence and temporal trends of physical activity counselling in primary health care in Germany from 1997-1999 to 2008-2011. Int J Behav Nutr Phys Act. 2015;12(1):136. doi:https://doi.org/10.1186/s12966-015-0299-9
- Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C. Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer. 2013;108(7):1515–1524. doi:https://doi.org/10.1038/bjc.2013.116
- McCowan C, Shearer J, Donnan PT, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer. 2008;99(11):1763–1768. doi:https://doi.org/10.1038/sj.bjc.6604758
- Winn AN, Dusetzina SB. The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer. Pharmacoepidemiol Drug Saf. 2016;25(8):953–959. doi:https://doi.org/10.1002/pds.4012
- Yood MU, Owusu C, Buist DS, et al. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg. 2008;206(1):66–75. doi:https://doi.org/10.1016/j.jamcollsurg.2007.07.015
- Bluethmann SM, Murphy CC, Tiro JA, Mollica MA, Vernon SW, Bartholomew LK. Deconstructing decisions to initiate, maintain, or discontinue adjuvant endocrine therapy in breast cancer survivors: a mixed-methods study. Oncol Nurs Forum. 2017;44(3):E101–E111. doi:https://doi.org/10.1188/17.ONF.E101-E110
- Brett J, Boulton M, Fenlon D, et al. Adjuvant endocrine therapy after breast cancer: a qualitative study of factors associated with adherence. Patient Prefer Adherence. 2018;12:291–300. doi:https://doi.org/10.2147/PPA.S145784
- Cahir C, Dombrowski SU, Kelly CM, Kennedy MJ, Bennett K, Sharp LJ . Women’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour. Support Care Cancer. 2015;23(11):3115–3130. doi:https://doi.org/10.1007/s00520-015-2685-x
- Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AMJ. Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care. 2007;45(5):431–439. doi:https://doi.org/10.1097/01.mlr.0000257193.10760.7f
- Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med. 2004;350(11):1081–1092. doi:https://doi.org/10.1056/NEJMoa040331
- Cuzick J. Aromatase inhibitors for breast cancer prevention. J Clin Oncol. 2005;23(8):1636–1643. doi:https://doi.org/10.1200/JCO.2005.11.027
- Howell A, Cuzick J, Baum M, et al . Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet. 2005;365(9453):60–62. doi:https://doi.org/10.1016/S0140-6736(04)17666-6
- Heiney SP, Parker PD, Felder TM, Adams SA, Omofuma OO, Hulett JM. A systematic review of interventions to improve adherence to endocrine therapy. Breast Cancer Res Treat. 2019;173(3):499–510. doi:https://doi.org/10.1007/s10549-018-5012-7
- Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91. doi:https://doi.org/10.3389/fphar.2013.00091
- Harrow A, Dryden R, McCowan C, et al. A hard pill to swallow: a qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancer. BMJ Open. 2014;4(6):e005285. doi:https://doi.org/10.1136/bmjopen-2014-005285
- Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and Commitment Therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25. doi:https://doi.org/10.1016/j.brat.2005.06.006
- Graham CD, Gouick J, Krahé C, Gillanders D. A systematic review of the use of Acceptance and Commitment Therapy (ACT) in chronic disease and long-term conditions. Clin Psychol Rev. 2016;46:46–58. doi:https://doi.org/10.1016/j.cpr.2016.04.009
- Hann KEJ, McCracken LM. A systematic review of randomized controlled trials of Acceptance and Commitment Therapy for adults with chronic pain. J Context Behav Sci. 2014;3(4):217–227. doi:https://doi.org/10.1016/j.jcbs.2014.10.001
- A-Tjak JG, Davis ML, Morina N, Powers MB, Smits JA, Emmelkamp PMJP. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 2015;84(1):30–36. doi:https://doi.org/10.1159/000365764
- Feros DL, Lane L, Ciarrochi J, Blackledge J. Acceptance and Commitment Therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psycho-Oncol. 2013;22(2):459–464.
- Marín FM, Soriano MCL. Acceptance of relapse fears in breast cancer patients: effects of an ACT-based abridged intervention. Psicooncología: investigación y Clínica Biopsicosocial en Oncología. 2016;13(1):7–21.
- Johns SA, Stutz PV, Talib TL, et al. Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: a 3‐arm pilot randomized controlled trial. Cancer. 2020;126(1):211–218. doi:https://doi.org/10.1002/cncr.32518
- Chunxiao Z, Lizu L, Lin Z, et al. The effects of acceptance and commitment therapy on the psychological and physical outcomes among cancer patients: a meta-analysis with trial sequential analysis. J Psychos Res. 2020;140:110304.
- Thewes B, Brebach R, Dzidowska M, Rhodes P, Sharpe L, Butow P. Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psychooncology. 2014;23(4):390–396. doi:https://doi.org/10.1002/pon.3423
- Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever R. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother. 2009;43(10):1621–1630. doi:https://doi.org/10.1345/aph.1M174
- Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:https://doi.org/10.1191/1478088706qp063oa
- Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi:https://doi.org/10.1093/intqhc/mzm042
- De Bono E. Six Thinking Hats. UK: Penguin; 2017.
- NHS Institute for Innovation and Improvement. Thinking differently. 2007.
- NHS Health Research Authority. http://www.hra-decisiontools.org.uk/research/
- Harris R. 2019. ACT Made Simple: An Easy-to-Read Primer on Acceptance and Commitment Therapy. New Harbinger Publications.
- Hayes SC, Hofmann SG, eds. 2018. Process-Based CBT: The Science and Core Clinical Competencies of Cognitive Behavioral Therapy. Oakland, CA: New Harbinger Publications.
- Rose MR, Norton S, Vari C, et al. Acceptance and Commitment Therapy for muscle disease (ACTMus): protocol for a two-arm randomised controlled trial of a brief guided self-help ACT programme for improving quality of life in people with muscle diseases. BMJ Open. 2018;8(10):e022083. doi:https://doi.org/10.1136/bmjopen-2018-022083
- Entwistle VA, France EF, Wyke S, et al. How information about other people’s personal experiences can help with healthcare decision-making: a qualitative study. Patient Educ Couns. 2011;85(3):e291–e8. doi:https://doi.org/10.1016/j.pec.2011.05.014
- Smith SG, Sestak I, Howell A, Forbes J, Cuzick J. Participant-reported symptoms and their effect on long-term adherence in the International Breast Cancer Intervention Study I (IBIS I). J Clin Oncol. 2017;35(23):2666–2673. doi:https://doi.org/10.1200/JCO.2016.71.7439
- Barry MJ, Edgman-Levitan S . Shared decision making-pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–781. doi:https://doi.org/10.1056/NEJMp1109283
- Mallinger JB, Griggs JJ, Shields CG . Patient-centered care and breast cancer survivors’ satisfaction with information. Patient Educ Couns. 2005;57(3):342–349. doi:https://doi.org/10.1016/j.pec.2004.09.009